First Hawaiian Bank Has $2.15 Million Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

First Hawaiian Bank cut its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.3% in the second quarter, Holdings Channel reports. The institutional investor owned 27,576 shares of the company’s stock after selling 935 shares during the quarter. First Hawaiian Bank’s holdings in GE HealthCare Technologies were worth $2,149,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of GEHC. Pathway Financial Advisers LLC acquired a new position in shares of GE HealthCare Technologies in the first quarter valued at $25,000. Turtle Creek Wealth Advisors LLC acquired a new position in shares of GE HealthCare Technologies in the fourth quarter valued at $30,000. BNP Paribas acquired a new position in shares of GE HealthCare Technologies in the first quarter valued at $30,000. Sachetta LLC acquired a new position in shares of GE HealthCare Technologies in the fourth quarter valued at $31,000. Finally, Rise Advisors LLC raised its stake in GE HealthCare Technologies by 241.4% during the first quarter. Rise Advisors LLC now owns 338 shares of the company’s stock worth $31,000 after acquiring an additional 239 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Down 2.3 %

GE HealthCare Technologies stock traded down $1.92 during mid-day trading on Monday, hitting $81.52. The stock had a trading volume of 3,587,342 shares, compared to its average volume of 3,141,184. The stock has a 50-day simple moving average of $78.91 and a two-hundred day simple moving average of $82.50. The stock has a market capitalization of $37.21 billion, a PE ratio of 23.84, a P/E/G ratio of 3.00 and a beta of 1.17. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, beating the consensus estimate of $0.98 by $0.02. The company had revenue of $4.84 billion during the quarter, compared to analysts’ expectations of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The business’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.92 earnings per share. As a group, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be given a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.15%. The ex-dividend date of this dividend is Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.51%.

Insiders Place Their Bets

In other GE HealthCare Technologies news, CTO Taha Kass-Hout sold 3,300 shares of the company’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total transaction of $259,710.00. Following the sale, the chief technology officer now directly owns 67,300 shares of the company’s stock, valued at $5,296,510. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CEO Jan Makela sold 20,227 shares of the stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $81.57, for a total value of $1,649,916.39. Following the transaction, the chief executive officer now directly owns 63,348 shares of the company’s stock, valued at $5,167,296.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CTO Taha Kass-Hout sold 3,300 shares of the company’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total transaction of $259,710.00. Following the completion of the transaction, the chief technology officer now owns 67,300 shares in the company, valued at $5,296,510. The disclosure for this sale can be found here. Over the last three months, insiders have sold 90,482 shares of company stock valued at $7,369,137. 0.27% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. The Goldman Sachs Group assumed coverage on GE HealthCare Technologies in a research note on Thursday, May 30th. They set a “neutral” rating and a $87.00 price objective for the company. Mizuho dropped their price objective on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research note on Wednesday, May 1st. Finally, Bank of America dropped their price objective on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Five research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $94.09.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.